ArticleTheranostics2025

Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy.

Xiaoke Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.